Marc Ladanyi
Marc Ladanyi publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Sarcoma Diagnosis and Treatment.
- World rank
- #14 of 7,710,434 ranked researchers
- Rank in United States
- #9 of 1,627,098
- Works
- 2,475
- Citations
- 217k
- Citations per work
- 87.7
What does Marc Ladanyi research?
Marc Ladanyi's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (30%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1,16647.1%
- Medicine1,16647.1%
- Life Sciences75230.4%
- Everything else55722.5%
- 1Pulmonary and Respiratory Medicine27% of their works
- 2Molecular Biology16% of their works
- 3Oncology15% of their works
- 4Cancer Research12% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Genetics2% of their works
Research topics
Which keywords describe Marc Ladanyi's research?
The keywords of their largest research topics: Targeted Therapy, Chemotherapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Cancer Genomics, Mutational Signatures and Prognostic Factors.
- KRAS Mutations
- Lymphoma
- Lung Cancer
- Molecular Characterization
- Small-Cell Lung Cancer
- Soft Tissue Sarcoma
- Prognostic Factors
- Cancer Genomics
- ALK Inhibitors
- Chemotherapy
- Targeted Therapy
- Clinical Trials
- EGFR Mutations
- Mutational Signatures
- Osteosarcoma
- Genomic Profiles
- Microsatellite Instability
- CT Screening
- Classification
- Cetuximab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Targeted Therapy7453 topics
- Chemotherapy4294 topics
- Clinical Trials4272 topics
- ALK Inhibitors3241 topic
- EGFR Mutations3241 topic
- Cancer Genomics3181 topic
- Mutational Signatures3181 topic
- Prognostic Factors3022 topics
- Osteosarcoma1991 topic
- Soft Tissue Sarcoma1991 topic
- Genomic Profiles1031 topic
- Small-Cell Lung Cancer1031 topic
- Microsatellite Instability721 topic
- Molecular Characterization721 topic
- CT Screening711 topic
- Lung Cancer711 topic
- Classification571 topic
- Lymphoma571 topic
- Cetuximab561 topic
- KRAS Mutations561 topic
Where does Marc Ladanyi work?
Marc Ladanyi's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.
How many publications and citations does Marc Ladanyi have?
OpenAlex counts 2,475 works and 217,139 citations for Marc Ladanyi, an h-index of 208, ranking #14 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Marc Ladanyi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marc Ladanyi. Posts are plain text and can be reported.